WINT · Windtree Therapeutics Inc /De/ · Analyst Estimates
$0.14
+0.03 (+24.55%)
At close · Aug 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 19, 2025
Substantial doubt about the company's ability to continue as a going concern.
“We do not have sufficient cash and cash equivalents as of the date of this Quarterly Report on Form 10-Q to support our operations for at least the 12 months following the date that the financial statements are issued. These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 19, 2025
Market Cap
$3,370
Shares
33.71M
Volume · Aug 21
6.7M
Avg daily vol (3M)
12.02M
Analyst Estimates
Compare analyst forecasts for Windtree Therapeutics Inc /De/ across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 11:55 UTC · Publication dates shown per estimate · 4 metric / period groups
FY ending 2025-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0
|
0
|
0
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|
Q ending 2025-03-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0
|
0
|
0
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|